애널리스트 10명 기준
목표가는 개별 리서치펌 단위가 아닌 시장 컨센서스(평균/최고/최저)입니다. 수집 액션 40건 · 최근 12개월 13건.
| 날짜 | 리서치펌 | 애널리스트 | 액션 | 의견 변화 | 목표가 | 리포트 |
|---|---|---|---|---|---|---|
| 2026. 05. 12. | Chardan Capital | — | 의견 유지 | Buy → Buy | — | Chardan Capital: Buy |
| 2026. 01. 13. | Chardan Capital | — | 의견 유지 | Buy → Buy | — | Chardan Capital: Buy |
| 2026. 01. 13. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 12. 18. | Raymond James | — | 커버리지 개시 | — → Strong Buy | — | Raymond James: Strong Buy |
| 2025. 12. 11. | Chardan Capital | — | 의견 유지 | Buy → Buy | — | Chardan Capital: Buy |
| 2025. 12. 01. | Cantor Fitzgerald | — | 커버리지 개시 | — → Overweight | — | Cantor Fitzgerald: Overweight |
| 2025. 11. 20. | Cantor Fitzgerald | — | 커버리지 개시 | — → Overweight | — | Cantor Fitzgerald: Overweight |
| 2025. 11. 06. | Chardan Capital | — | 의견 유지 | Buy → Buy | — | Chardan Capital: Buy |
| 2025. 10. 21. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 10. 15. | Guggenheim | — | 커버리지 개시 | — → Buy | — | Guggenheim: Buy |
| 2025. 10. 08. | Chardan Capital | — | 의견 유지 | Buy → Buy | — | Chardan Capital: Buy |
| 2025. 10. 08. | Leerink Partners | — | 의견 유지 | Outperform → Outperform | — | Leerink Partners: Outperform |
| 2025. 10. 07. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 08. 16. | Chardan Capital | — | 의견 유지 | Buy → Buy | — | Chardan Capital: Buy |
| 2025. 08. 16. | Leerink Partners | — | 의견 유지 | Outperform → Outperform | — | Leerink Partners: Outperform |
| 2025. 08. 15. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 07. 31. | Oppenheimer | — | 커버리지 개시 | — → Outperform | — | Oppenheimer: Outperform |
| 2025. 05. 30. | JP Morgan | — | 의견 유지 | Overweight → Overweight | — | JP Morgan: Overweight |
| 2025. 05. 16. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 05. 13. | Chardan Capital | — | 의견 유지 | Buy → Buy | — | Chardan Capital: Buy |
| 2025. 05. 13. | Leerink Partners | — | 의견 유지 | Outperform → Outperform | — | Leerink Partners: Outperform |
| 2025. 04. 08. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 04. 08. | Chardan Capital | — | 의견 유지 | Buy → Buy | — | Chardan Capital: Buy |
| 2025. 03. 26. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 03. 26. | RBC Capital | — | 의견 유지 | Outperform → Outperform | — | RBC Capital: Outperform |
| 2025. 03. 25. | Chardan Capital | — | 의견 유지 | Buy → Buy | — | Chardan Capital: Buy |
| 2025. 03. 25. | Leerink Partners | — | 의견 유지 | Outperform → Outperform | — | Leerink Partners: Outperform |
| 2025. 01. 22. | RBC Capital | — | 의견 유지 | Outperform → Outperform | — | RBC Capital: Outperform |
| 2024. 11. 14. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2024. 11. 14. | Chardan Capital | — | 의견 유지 | Buy → Buy | — | Chardan Capital: Buy |
| 2024. 11. 14. | Leerink Partners | — | 의견 유지 | Outperform → Outperform | — | Leerink Partners: Outperform |
| 2024. 10. 31. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2024. 10. 31. | Chardan Capital | — | 의견 유지 | Buy → Buy | — | Chardan Capital: Buy |
| 2024. 10. 26. | Chardan Capital | — | 의견 유지 | Buy → Buy | — | Chardan Capital: Buy |
| 2024. 08. 14. | Chardan Capital | — | 의견 유지 | Buy → Buy | — | Chardan Capital: Buy |
| 2024. 08. 14. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2024. 08. 14. | RBC Capital | — | 의견 유지 | Outperform → Outperform | — | RBC Capital: Outperform |
| 2024. 07. 16. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2024. 07. 16. | Chardan Capital | — | 의견 유지 | Buy → Buy | — | Chardan Capital: Buy |
| 2024. 06. 13. | Baird | — | 커버리지 개시 | — → Outperform | — | Baird: Outperform |
